PNC-27 10mg
This anticancer peptide has demonstrated selective cytotoxicity against cancer cells in laboratory studies while leaving healthy cells unharmed. Research has shown its ability to bind to HDM-2 proteins in cancer cell membranes, creating pores that lead to rapid tumor cell death. Studies have documented efficacy against various cancer types including pancreatic, breast, and leukemia cells in preclinical models. The peptide has gained attention in oncology research for its novel mechanism of action and potential as a targeted cancer therapy with minimal side effects.
This anticancer peptide has demonstrated selective cytotoxicity against cancer cells in laboratory studies while leaving healthy cells unharmed. Research has shown its ability to bind to HDM-2 proteins in cancer cell membranes, creating pores that lead to rapid tumor cell death. Studies have documented efficacy against various cancer types including pancreatic, breast, and leukemia cells in preclinical models. The peptide has gained attention in oncology research for its novel mechanism of action and potential as a targeted cancer therapy with minimal side effects.
Purity: ≥99% Purity · Formula: C188H293N53O44S · CAS: 1159861-00-3
Fulfilled and shipped direct by MedFit. Orders are confirmed by email, and we follow up on protocol questions ourselves — call the studio any time.